Loading stock data…
EHTH
$2.04-0.02 (-0.97%)
Market ClosedLast close May 1
eHealth, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
eHealth, Inc. in the Financial Services sector is trading at $2.04. The stock is currently near its 52-week low of $1.20, remaining 38.2% below its 200-day moving average. Technical signals show overbought RSI of 74 and bullish MACD crossover, explaining why EHTH maintains its current current market pressure. The Whystock Score of 0/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 74) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$2.04
Potential Upside
5%
Whystock Fair Value$2.14
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus4 analysts
Hold
Mean target$2.25+10.3%
Range$2.00 – $3.00
Fundamentals
eHealth, Inc. operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. It operates in two segments, Medicare; and Employer and Individual. The Medicare segme...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$53.45M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.15
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.77%
Volume
Today's trading volume
257,494
Recent News
Willis Towers Watson (WTW) Tops Q1 Earnings and Revenue Estimates
Willis Towers Watson (WTW) delivered earnings and revenue surprises of +3.66% and +1.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
April 2026's Top Penny Stocks With Strong Fundamentals
Over the last 7 days, the U.S. market has risen 1.3%, and over the past year, it is up by an impressive 35%, with earnings forecasted to grow annually by 16%. In light of these robust market conditions, identifying stocks with strong fundamentals becomes crucial for investors seeking stability and growth. While penny stocks might seem like a relic from past trends, they continue to offer intriguing opportunities in smaller or newer companies that demonstrate financial resilience and potential...
How The eHealth (EHTH) Investment Story Is Reset As Analysts Cut Targets And Expectations
eHealth’s fair value estimate has been cut from US$3.75 to US$2.25 per share, marking a clear reset in what analysts are willing to pay for the story. Recent Street research, including price target moves from US$9 to US$3 and from US$8 to US$2, aligns with this shift as expectations adjust to the latest 2026 revenue guidance and related commentary. Read on to see how this evolving narrative may influence your view of the stock over the coming quarters. Stay updated as the Fair Value for...
eHealth, Inc. (EHTH) PT Slashed From $9 to $3 at RBC Amid Softer 2026 Outlook
We recently compiled a list of the 10 Oversold Insurance Stocks to Buy According to Analysts. eHealth, Inc. (NASDAQ:EHTH) is one of the most oversold insurance stocks on this list. TheFly reported on March 11 that EHTH saw its price target reduced by RBC Capital to $3 from $9, while the firm reiterated a Sector Perform rating […]
How The eHealth (EHTH) Investment Story Is Resetting Around Lower Growth And Higher Margins
eHealth’s latest analyst update centers on a sharp reset in price expectations, with fair value moving from US$8.50 to US$3.75. That shift lines up with research notes where price targets now cluster around US$2 and ratings are mostly at Hold, as analysts weigh more cautious revenue assumptions against a higher focus on profitability and customer acquisition efficiency. As you read on, you will see how this evolving narrative might influence how you track eHealth from here. Stay updated as...